Counsel Portfolio Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$2.91M Hold
35,262
0.29% 112
2016
Q1
$2.68M Hold
35,262
0.35% 84
2015
Q4
$2.83M Sell
35,262
-8,488
-19% -$612K 0.3% 100
2015
Q3
$2.78M Hold
43,750
0.3% 98
2015
Q2
$3.08M Hold
43,750
0.31% 103
2015
Q1
$3.47M Sell
43,750
-10,864
-20% -$801K 0.35% 97
2014
Q4
$3.48M Hold
54,614
0.35% 86
2014
Q3
$3.26M Buy
54,614
+6,180
+13% +$354K 0.34% 93
2014
Q2
$2.59M Hold
48,434
0.24% 122
2014
Q1
$2.92M Sell
48,434
-15,511
-24% -$904K 0.29% 104
2013
Q4
$3.39M Hold
63,945
0.35% 90
2013
Q3
$2.96K Hold
63,945
0.15% 96
2013
Q2
$2.62M Buy
+63,945
New +$2.74M 0.32% 102

Other funds holding CRL

Counsel Portfolio Services's CRL Position: Q2 2016 in Review

Counsel Portfolio Services held its Charles River Laboratories (CRL) position steady in Q2 2016 at 35,262 shares worth $2.91M. The position accounts for 0.29% of the portfolio, ranked #112.

Counsel Portfolio Services first reported a position in CRL in Q2 2013 and has held it in 13 quarters since. The position peaked at $3.48M in Q4 2014. 286 funds tracked by Wall St. Rank hold CRL as of Q2 2016.

  • Counsel Portfolio Services held 35,262 shares of Charles River Laboratories worth $2.91M as of Q2 2016.
  • Counsel Portfolio Services left its Charles River Laboratories share count unchanged in Q2 2016.
  • Charles River Laboratories made up 0.29% of Counsel Portfolio Services's portfolio in Q2 2016, its #112 holding.
  • Counsel Portfolio Services first reported a position in Charles River Laboratories in Q2 2013 and has held it in 13 quarters since.
  • Counsel Portfolio Services's Charles River Laboratories position peaked at $3.48M in Q4 2014.
  • 286 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2016.

Based on Counsel Portfolio Services's 13F filing for Q2 2016, filed 12 Aug 2016.